Effects of socioeconomic status on colon cancer treatment accessibility and survival in Toronto, Ontario, and San Francisco, California, 1996-2006

American Journal of Public Health

Volumn 101, Issue 1, 2011, Pages 112-119

  Gorey, Kevin M ^a   Luginaah, Isaac N ^a   Bartfay, Emma ^a   Fung, Karen Y ^a   Holowaty, Eric J ^a   Wright, Frances C ^a   Hamm, Caroline ^a   Kanjeekal, Sindu M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANADA; COLON TUMOR; COMPARATIVE STUDY; EARLY DIAGNOSIS; FEMALE; HEALTH CARE DELIVERY; HEALTH DISPARITY; HOSPITAL ADMISSION; HUMAN; MALE; MIDDLE AGED; MORTALITY; SOCIAL CLASS; STATISTICAL MODEL; SURVIVAL RATE; UNITED STATES;

ADULT; AGED; AGED, 80 AND OVER; COLONIC NEOPLASMS; EARLY DIAGNOSIS; FEMALE; HEALTH SERVICES ACCESSIBILITY; HEALTH STATUS DISPARITIES; HUMANS; LIKELIHOOD FUNCTIONS; MALE; MIDDLE AGED; ONTARIO; SAN FRANCISCO; SOCIAL CLASS; SURVIVAL RATE; WAITING LISTS;

EID: 78650887212     PISSN: 00900036     EISSN: 15410048     Source Type: Journal    
DOI: 10.2105/AJPH.2009.173112     Document Type: Article

References (70)

1. Gorey KM, Holowaty EJ, Fehringer G, et al. An international comparison of cancer survival: Toronto, Ontario, and Detroit, Michigan, metropolitan areas. Am J Public Health. 1997;87(7):1156-1163.
2. Gorey KM. Breast cancer survival in Canada and the USA: meta-analytic evidence of a Canadian advantage in low-income areas. Int J Epidemiol. 2009;38(6):1543-1551.
3. Gorey KM, Fung KY, Luginaah IN, Holowaty EJ, Hamm C. Income and long-term breast cancer survival: comparisons of vulnerable urban places in Ontario and California. Breast J. 2010;16(4):416-419.
4. Gorey KM, Luginaah IN, Hamm C, Fung KY, Holowaty EJ. Breast cancer care in Canada and the United States: ecological comparisons of extremely impoverished and affluent urban neighborhoods. Health Place. 2010;16(1):156-163.
5. Gorey KM, Luginaah IN, Holowaty EJ, Fung KY, Hamm C. Wait times for surgical and adjuvant radiation treatment of breast cancer in Canada and the United States: greater socioeconomic inequity in America. Clin Invest Med. 2009;32(3):E239-E249.
6. Gorey KM, Luginaah IN, Holowaty EJ, Fung KY, Hamm C. Breast cancer survival in Ontario and California, 1998 to 2006: socioeconomic inequity remains much greater in the United States. Ann Epidemiol. 2009;19(2):121-124.
7. Steering Committee. Canadian Cancer Statistics, 2009. Toronto, Ontario: Canadian Cancer Society; 2009.
8. Horner MJ, Ries LAG, Krapcho M, et al., eds. SEER Cancer Statistics Review, 1975-2006. Bethesda, MD: National Cancer Institute; 2009.
9. Gorey KM, Holowaty EJ, Fehringer G, Laukkanen E, Richter NL, Meyer CM. An international comparison of cancer survival: relatively poor areas of Toronto, Ontario, and three US metropolitan areas. J Public Health Med. 2000;22(3):343-348.
10. Zhang-Salomons J, Qian H, Holowaty E, Mackillop WJ. Associations between socioeconomic status and cancer survival: choice of SES indicator may affect results. Ann Epidemiol. 2006;16(7):521-528.
11. Boyd C, Zhang-Salomons JY, Groome PA, Mackillop WJ. Associations between community income and cancer survival in Ontario, Canada, and the United States. J Clin Oncol. 1999;17(7):2244-2255.
12. Lincourt AE, Sing RF, Kercher KW, et al. Association of demographic and treatment variables in longterm colon cancer survival. Surg Innov. 2008;15(1): 17-25.
13. Polednak AP. Poverty, comorbidity, and survival of colorectal patients in Connecticut. J Health Care Poor Underserved. 2001;12(3):302-310.
14. Chao A, Connell CJ, Cokkinides V, Jacobs EJ, Calle EE, Thun MJ. Underuse of screening sigmoidoscopy and colonoscopy in a large cohort of US adults. Am J Public Health. 2004;94(10):1775-1781.
15. Bressler B, Lo C, Amar J, et al. Prospective evaluation of screening colonoscopy: who is being screened? Gastrointest Endosc. 2004;60(6):921-926.
16. Wirtzfeld DA, Mikula L, Gryfe R, et al. Concordance with clinical practice guidelines for adjuvant chemotherapy in patients with stage I-III colon cancer: experience in 2 Canadian provinces. Can J Surg. 2009;52(2):92-97.
17. Figueredo A, Coombes ME, Mukherjee S. Adjuvant therapy for completely resected stage II colon cancer. Cochrane Database Syst Rev. 2008;(3): CD005390.
18. Etzioni DA, El-Khoueiry AB, Beart RW. Rates and predictors of chemotherapy use for stage III colon cancer: a systematic review. Cancer. 2008;113(12):3279-3289.
19. Thorpe LE, Mostashari F, Hajat A, et al. Colon cancer screening practices in New York City, 2003: Results of a large random-digit dialed telephone survey. Cancer. 2005;104(5):1075-1082.
20. Halpern MT, Pavluck AL, Ko CY, Ward EM. Factors associated with colon cancer stage at diagnosis. Dig Dis Sci. 2009;54(12):2680-2693.
21. Schwartz KL, Crossley-May H, Vigneau FD, Brown K, Banerjee M. Race, socioeconomic status and stage at diagnosis for five common malignancies. Cancer Causes Control. 2003;14(8):761-766.
22. VanEenwyk J, Campo JS, Ossiander EM. Socioeconomic and demographic disparities in treatment of carcinoma of the colon and rectum. Cancer. 2002; 95(1):39-46.
23. Singh SM, Paszat LF, Li C, He J, Vinden C, Rabeneck L. Association of socioeconomic status and receipt of colorectal cancer investigations: a populationbased retrospective cohort study. CMAJ. 2004;171(5): 461-465.
24. Gorey KM, Holowaty EJ, Laukkanen E, Fehringer G, Richter NL. An international comparison of cancer survival: advantage of Toronto's poor over the near poor of Detroit. Can J Public Health. 1998;89(2):102-104.
25. International Classification of Diseases, Ninth Revision. Geneva, Switzerland: World Health Organization; 1980.
26. Profiles of Census Tracts and Census Subdivisions, 2001 (Ontario). Ottawa: Statistics Canada; 2002.
27. 2000 Census of Population and Housing in California: Summary Tape File 3 on CD-ROM. Washington, DC: US Census Bureau; 2002.
28. Fleiss JL. Statistical Methods for Rates and Proportions. 2nd ed. New York, NY: John Wiley & Sons; 1981.
29. Hall S, Schulze K, Groome P, Mackillop W, Holowaty E. Using cancer registry data for survival studies: the example of the Ontario Cancer Registry. J Clin Epidemiol. 2006;59(1):67-76.
30. Walter SD, Birnie SE, Marrett LD, et al. The geographic variation of cancer incidence in Ontario. Am J Public Health. 1994;84(3):367-376.
31. North American Association of Central Cancer Registries. Data quality assessments, 2008. Available at: http://www.naaccr.org. Accessed May 12, 2009.
32. National Cancer Institute. Surveillance, epidemiology, and end results (SEER), 2008. Available at: http://www.seer.cancer.gov. Accessed May 12, 2009.
33. California Cancer Registry. Cancer Reporting in California: Abstracting and Coding Procedures for Hospitals. California Cancer Reporting System Standards. Vol 1. 7th ed. Sacramento, CA: Department of Health Services, Cancer Surveillance Section; 2003.
34. Greene FL, Page DL, Fleming ID, et al., eds. AJCC Staging Manual. 6th ed. New York, NY: Springer-Verlag; 2002.
35. Fritz A, Ries L, eds. SEER Extent of Disease: Codes and Coding Instructions. 3rd ed. Bethesda, MD: National Cancer Institute; 1998.
36. Osberg L. Poverty in Canada and the United States: measurement, trends, and implications. Can J Econ. 2000;33(4):847-877.
37. Gorey KM, Vena JE. The association of near poverty status with cancer incidence among Black and White adults. J Community Health. 1995;20(4):359-366.
38. Krieger N, Chen JT, Waterman PD, Rehkopf DH, Subramanian SV. Race/ethnicity, gender, and monitoring socioeconomic gradients in health: a comparison of areabased socioeconomic measures - the Public Health Disparities Geocoding Project. Am J Public Health. 2003;93(10):1655-1671.
39. Krieger N, Chen JT, Waterman PD, Soobader M, Subramanian SV, Carson R. Geocoding and monitoring of US socioeconomic inequalities in mortality and cancer incidence: does the choice of area-based measure and geographic level matter? The Public Health Disparities Geocoding Project. Am J Epidemiol. 2002;156(5):471-482.
40. Organization for Economic Co-Operation and Development. Purchasing power parities. Available at: http://www.oecd.org/std/ppp. Accessed February 12, 2009.
41. Lafrance R, Schembri L. Purchasing-power parity: definition, measurement, and interpretation. Bank Can Rev. Autumn 2002:27-33.
42. Hosmer DW, Lemeshow S. Applied Logistic Regression. 2nd ed. New York, NY: John Wiley & Sons; 2000.
43. Gorey KM. Regarding "Associations between socioeconomic status and cancer survival." Ann Epidemiol. 2006;16(10):789-791.
44. Greenland S. Introduction to regression modeling. In: Rothman KJ, Greenland S, eds. Modern Epidemiology. 2nd ed. Philadelphia, PA: Lippincott-Raven Publishers; 1998:401-432.
45. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22(4):719-748.
46. Miettinen OS. Estimability and estimation in casereferent studies. Am J Epidemiol. 1976;103(2):226-235.
47. Wright FC, Law CHL, Berry S, Smith AJ. Clinically important aspects of lymph node assessment in colon cancer. J Surg Oncol. 2009;99(4):248-255.
48. Bilimoria KY, Bentrem DJ, Stewart AK, et al. Lymph node evaluation as a colon cancer quality measure: a national hospital report card. J Natl Cancer Inst. 2008;100(18):1310-1317.
49. Chang GJ, Rodriguez-Bigas MA, Skibber JM, Moyer VA. Lymph node evaluation and survival after curative resection of colon cancer: systematic review. J Natl Cancer Inst. 2007;99(6):433-441.
50. Starfield B. Commentary: how does 'insurance' improve equity in health? Int J Epidemiol. 2009;38(6): 1551-1553.
51. De Bosset V, Atashili J, Miller W, Pignone M. Health insurance-related disparities in colorectal cancer screening in Virginia. Cancer Epidemiol Biomarkers Prev. 2008;17(4):834-837.
52. Halpern MT, Ward EM, Pavluck AL, Schrag NM, Bian J, Chen AY. Association of insurance status and ethnicity with cancer stage at diagnosis for 12 cancer sites: a retrospective analysis. Lancet Oncol. 2008; 9(3):222-231.
53. Bradley CJ, Given CW, Roberts C. Late stage cancers in a Medicaid-insured population. Med Care. 2003;41(6):722-728.
54. Bradley CJ, Given CW, Dahman B, Fitzgerald TL. Adjuvant chemotherapy after resection in elderly Medicare and Medicaid patients with colon cancer. Arch Intern Med. 2008;168(5):521-529.
55. McDavid K, Tucker TC, Sloggett A, Coleman MP. Cancer survival in Kentucky and health insurance coverage. Arch Intern Med. 2003;16(18)3:2135-2144.
56. Bradley CJ, Given CW, Roberts C. Disparities in cancer diagnosis and survival. Cancer. 2001;91(1):178-188.
57. Roetzheim RG, Pal N, Gonzalez EC, Ferrante JM, Van Durme DJ, Krischer JP. Effects of health insurance and race on colorectal cancer treatments and outcomes. Am J Public Health. 2000;90(11):1746-1754.
58. Rabeneck L, Paszat LF. A population-based estimate of the extent of colorectal cancer screening in Ontario. Am J Gastroenterol. 2004;99(6):1141- 1144.
59. Cancer Care Ontario. Colon cancer check. Available at: http://www.coloncancercheck.ca. Accessed May 24, 2009.
60. Gross CP, Smith BD, Wolf E, Andersen M. Racial disparities in cancer therapy: did the gap narrow between 1992 and 2002? Cancer. 2008;112(4):900-908.
61. Le H, Ziogas A, Lipkin SM, Zell JA. Effects of socioeconomic status and treatment disparities in colorectal cancer survival. Cancer Epidemiol Biomarkers Prev. 2008;17(8):1950-1962.
62. Du XL, Meyer TE, Franzini L. Meta-analysis of racial disparities in survival in association with socioeconomic status among men and women with colon cancer. Cancer. 2007;109(11):2161-2170.
63. Gomez SL, O'Malley CD, Stroup A, Shema SJ, Satariano WA. Longitudinal, population-based study of racial/ethnic differences in colorectal cancer survival: impact of neighborhood socioeconomic status, treatment and comorbidity. BMC Cancer. 2007(7):193.
64. Jargowsky PA. Poverty and Ghettos Place: Barrios, and the American City. New York, NY: Russell Sage Foundation; 1997.
65. Lund MJ, Brawley OP, Ward KC, Young JL, Gabram SS, Eley JW. Parity and disparity in first course treatment of invasive breast cancer. Breast Cancer Res Treat. 2008;109(3):545-557.
66. Malin JL, Kahn KL, Adams J, Kwan L, Laouri M, Ganz PA. Validity of cancer registry data for measuring the quality of breast cancer care. J Natl Cancer Inst. 2002;94(11):835-844.
67. Cress RD, Zaslavsky AM, West DW, Wolf RE, Felter MC, Ayanian JZ. Completeness of information on adjuvant therapies for colorectal cancer in populationbased cancer registries. Med Care. 2003;41(9):1006-1012.
68. Cooper GS, Virnig B, Klabunde CN, Schussler N, Freeman J, Warren JL. Use of SEER-Medicare data for measuring cancer surgery. Med Care. 2002;40(8):IV-43-IV-48.
69. Brown BW, Brauner C, Minnotte MC. Noncancer deaths in White adult cancer patients. J Natl Cancer Inst. 1993;85(12):979-987.
70. Lenfant C, Freidman L, Thom T. Fifty years of death certificates: the Framingham Heart Study. Ann Intern Med. 1998;129(12):1066-1067.